Emmanuelle Coutanceau

Partner, Novo Seeds

Emmanuelle joined Novo A/S in September 2015 as Investment Director of Novo Seeds. She led the Series B investments in Corwave, and serves on the Boards of Adenium Biotech, Antag Therapeutics, Avilex Pharma, Corwave, Inthera Bioscience, MinervaX and Pcovery.

Emmanuelle has close to 10 years of experience in venture capital investment. Prior joi...

Roles at Novo Holdings

  • Partner, Novo Seeds

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.